Table 2.
Comparison | Gene name (DASL) | TargetID (HM450) | Relation to UCSC CpG Island | Functional Location | Enhancer | Spearman, r | Spearman, P-value |
---|---|---|---|---|---|---|---|
HBV vs HCV | MFSD7 | cg05827190 | Island | Body | Enhancer | -0.41 | 0.0315 |
HBV vs HCV | FLNC | cg02661879 | Island | 5'UTR;1stExon | Non-enhancer | -0.43 | 0.0221 |
HBV vs NIV | ATF5 | cg04315771 | S_Shore | TSS1500;5'UTR | Non-enhancer | -0.64 | 0.0003 |
HBV vs NIV | KIAA1199 | cg02585724 | Opensea | 5'UTR | Enhancer | 0.40 | 0.0357 |
HCV vs NIV | AXIN2 | cg09231741 | Island | Body | Non-enhancer | 0.45 | 0.0156 |
HCV vs NIV | CES3 | cg26538442 | Opensea | TSS200 | Enhancer | -0.48 | 0.0099 |
HCV vs NIV | DHRS3 | cg26029221 | N_Shelf | Body | Enhancer | -0.51 | 0.0054 |
HCV vs NIV | HOXA6 | cg23129930 | Island | 1stExon | Non-enhancer | 0.45 | 0.0161 |
HCV vs NIV | IGFBP4 | cg02627216 | N_Shore | TSS1500 | Non-enhancer | -0.44 | 0.0199 |
HCV vs NIV | LRRC17 | cg20066782 | Opensea | Body | Enhancer | -0.45 | 0.0169 |
HCV vs NIV | RAB11FIP4 | cg07146073 | Opensea | Body | Enhancer | 0.51 | 0.0055 |
HCV vs NIV | ROR1 | cg03937361 | Opensea | Body | Enhancer | 0.67 | 0.0001 |
HCV vs NIV | ROR1 | cg13942627 | Opensea | Body | Enhancer | 0.44 | 0.0193 |
HCV vs NIV | SGIP1 | cg09665332 | Opensea | Body | Enhancer | -0.52 | 0.0046 |
HCV vs NIV | STEAP2 | cg06112923 | Opensea | Body;3'UTR | Non-enhancer | 0.51 | 0.0057 |